IRIS
MORONCINI, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.966
EU - Europa 2.106
AS - Asia 523
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
SA - Sud America 2
AF - Africa 1
Totale 6.608
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.957
IT - Italia 538
UA - Ucraina 405
SE - Svezia 302
IE - Irlanda 291
DE - Germania 214
TR - Turchia 160
DK - Danimarca 149
CN - Cina 132
SG - Singapore 114
FI - Finlandia 81
KR - Corea 78
GB - Regno Unito 75
IN - India 16
BE - Belgio 14
FR - Francia 11
CA - Canada 9
IL - Israele 7
EU - Europa 5
PL - Polonia 5
RO - Romania 5
AU - Australia 4
JP - Giappone 4
RS - Serbia 4
MY - Malesia 3
AL - Albania 2
CH - Svizzera 2
NL - Olanda 2
PK - Pakistan 2
PT - Portogallo 2
TW - Taiwan 2
YE - Yemen 2
AT - Austria 1
BD - Bangladesh 1
BR - Brasile 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 6.608
Salva come PNG Salva come JPEG
Città #
Chandler 621
Jacksonville 426
Fairfield 334
Dublin 286
Ashburn 266
Des Moines 261
Wilmington 186
Woodbridge 155
Centro 149
Boardman 144
Houston 142
New York 142
Seattle 126
Ann Arbor 115
Lawrence 108
Princeton 108
San Mateo 92
Cambridge 80
Redmond 45
Turin 37
San Diego 35
Beijing 34
Marche 30
Tolentino 30
Washington 23
Los Angeles 20
London 19
Jesi 17
Singapore 17
Ancona 16
Pune 14
Brussels 12
Falls Church 11
Kilburn 11
Milan 11
Shanghai 10
Helsinki 9
Izmir 8
Norwalk 7
Wuhan 7
Guangzhou 6
Macerata 6
Monte San Pietrangeli 6
Southwark 6
West Jordan 6
Ascoli Piceno 5
Chiaravalle 5
Falconara Marittima 5
Jerusalem 5
Jiaxing 5
Nürnberg 5
Osimo 5
Ottawa 5
Rome 5
Squinzano 5
Auburn Hills 4
Belgrade 4
Brisbane 4
Bucharest 4
Fermo 4
Genoa 4
Montelupone 4
Scuola 4
Yiwu 4
Camerino 3
Jinhua 3
Montréal 3
New Bedfont 3
Pagani 3
Pesaro 3
Petaling Jaya 3
Porto 3
Senigallia 3
Shenzhen 3
Bengaluru 2
Brescia 2
Buffalo 2
Dongguan 2
Fabriano 2
Florence 2
Gessate 2
Hanover 2
Hounslow 2
Leawood 2
Lisbon 2
Montefortino 2
Montelabbate 2
Monza 2
Nuremberg 2
Pergola 2
Pisa 2
Sanaa 2
Seoul 2
Taipei 2
Tavullia 2
Tel Aviv 2
Weihai 2
Abidjan 1
Acton 1
Amsterdam 1
Totale 4.359
Salva come PNG Salva come JPEG
Nome #
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 116
The first outstanding 50 years of “Università Politecnica delle Marche”: Research achievements in life sciences 116
The value of admission Troponin I to predict outcomes in suspected infections in elderly patients admitted in Internal Medicine: results from the SOFA-T collaboration, a multi-center study 116
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 114
Preface 108
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud'€™s phEnomenon (SUNSHINE survey) 103
Atrial Fibrillation on Patients with Vascular Dementia: A Fundamental Target for Correct Management 98
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 96
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 96
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 95
Development of the optimal touchscreen interface for patients with scleroderma 95
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 93
Hypothalamic-pituitary-adrenal axis disregulation in PrPC-null mice. 90
Adalimumab modulates angiogenesis in psoriatic skin 88
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 87
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 85
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 83
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 83
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 81
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 80
Pathogenic autoantibodies in systemic sclerosis 79
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 78
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 75
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 75
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 73
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 72
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway 72
Low-dose Oral Imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide. A phase II pilot study 72
MOTIF-GRAFTED HYBRID POLYPEPTIDES AND USES THEREOF 71
Analysis of ATP8B4 F436L missense variant in a large systemic sclerosis cohort 71
Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies. 71
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 70
SOFA and qSOFA usefulness for in-hospital death prediction of elderly patients admitted for suspected infection in internal medicine 70
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 69
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 68
Downregulation of GPR83 in the hypothalamic preoptic area reduces core body temperature and elevates circulating levels of adiponectin. 67
Delection of typical and atypical bovine spongiform encephalopathy and scraipe prion strains by prion protein motif-grafted antibodies 65
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. 64
Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al. 64
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 64
Biologics in inflammatory immune-mediated systemic diseases 64
History and scientific production of clinica medica and clinica ematologica in ancona 64
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 64
Detection of typical and atypical BSE and scrapie prion strains by prion protein motif-grafted antibodies. 63
Agonistic antibodies in systemic sclerosis 63
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 63
Reactivation of Hepatitis B Virus Infection Associated with Anti-Tumor Necrosis Factor-α Therapy 62
Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin 62
Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation. 61
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 61
Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. 61
Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance 61
Update of EULAR recommendations for the treatment of systemic sclerosis 60
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 60
BIOLOGIC THERAPY IN INFLAMMATORY IMMUNOMEDIATED SYSTEMIC DISEASES: SAFETY PROFILE 60
Stimulatory Auto-Antibodies To The PDGF Receptor As Pathology Marker And Therapeutic Target 59
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 59
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways 59
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. 58
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 57
Putative functional pathogenic autoantibodies in systemic sclerosis 57
Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress 54
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 54
Role of viral infections in the etiopathogenesis of systemic sclerosis 53
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 53
Epitopes of the human PDGF receptor able to bind human auto-antibodies, antibodies and uses thereof 52
Development of A Solid Phase Binding Assay For Detection of Conformational Anti-PDGFR Autoantibodies In the Serum of Patients Affected By Scleroderma 51
NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis 50
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 49
CLONING OF AGONISTIC AUTOANTIBODIES SPECIFIC FOR THE PDGF RECEPTOR FROM THE B CELL REPERTOIRE OF PATIENTSAFFECTED BY SYSTEMIC SCLEROSIS 49
Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc 49
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 48
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 48
Reply 48
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 46
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 44
Oxidative DNA damage induces the ATM-mediated transcriptional suppressionof the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis 44
null 44
Letter to the Editor. Reply to Magalon J et al. (CT-1406) 43
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 42
New insights into the role of oxidative stress in scleroderma fibrosis. 42
The proinflammatory cytokine interleukin 18 regulates feeding by acting on the bed nucleus of the stria terminalis 42
Treatment With Rituximab Reduces Activation Of Scleroderma Dermal Fibroblasts 41
Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody 40
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. 40
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 38
Monoacylglycerol lipase regulates fever response 37
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 37
Restricted immunoglobulin repertoire and evolutionary mechanism of PDGFR-autoreactive memory B cells in systemic sclerosis 36
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease 36
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 36
STIMULATORY AUTOANTIBODIES AGAINST PDGF RECEPTOR IN A LARGE COHORT OF ITALIAN SCLERODERMA PATIENTS 35
Improving the EHMRG Prognostic Evaluation of Acute Heart Failure with TAPSE/PASp: A Sequential Approach 34
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 34
Current take on systemic sclerosis patients’ vaccination recommendations 34
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 33
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 32
Rituximab for the treatment of cutaneous involvement in systemic sclerosis. evidence for a pathogenetic role of B-CELLS 32
The Wnt signalling inhibitor gene, WIF1, is silenced in fibroblasts derived from Systemic Sclerosis patients: role of oxidative stress 31
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 31
Totale 6.253
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.875
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020547 8 4 94 4 87 7 95 10 90 7 27 114
2020/20211.469 67 141 176 3 185 98 177 104 162 129 152 75
2021/2022865 44 190 23 29 22 43 20 53 83 57 125 176
2022/20231.821 148 189 128 162 113 403 9 101 382 24 122 40
2023/20241.153 163 38 66 138 167 233 21 51 11 82 57 126
2024/202534 34 0 0 0 0 0 0 0 0 0 0 0
Totale 6.821